Syngene is a full-scale contract research organization (CRO) and contract development and manufacturing organization (CDMO) with extensive experience.
Our small molecules Discovery Services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. Our services cover Chemistry, Biology, Safety Assessment & Toxicology, and Computational & Data Sciences. Additionally, we also support integrated drug discovery for small molecules with SynVent – Syngene’s platform for fully integrated therapeutic discovery and development.
Syngene offers preclinical development, API and drug product development. We offer drug development services from lead generation to clinical supplies of drug substance and drug product. Our Clinical development services are across Phase I, II & III trials. We also support our clients in drug filing with FDA and other global regulatory authorities.
What sets our Development services apart, is our full-service capability and well-rounded expertise to enable seamless integration of R&D programs, resulting in faster go-to-market opportunity for our clients.
Syngene has capabilities for current good manufacturing practices (cGMP) manufacturing from benchtop volume to commercial scale. Since 2015, we have generated around 150 metric tons of materials for various projects. We offer end-to-end solutions from GLP-Tox batches to clinical supplies, scale up, launch and commercial manufacturing.